Citations

Mayo Clinic

Showing 10 of 108551 citations.

Androgen loss weakens anti-tumor immunity and accelerates brain tumor growth
Lathia, Justin D. , Silver, Daniel J. , Hao, Yue , Li, Cathy , Volovetz, Josephine , Hong, Ellen S. , Jarmula, Jakub , Swanson, Kristin R. , Sharifi, Nima , Silver, Daniel J , Berens, Michael E , Swanson, Kristin R , Lathia, Justin D

No container title available | March 29, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-4014556/v1 | PMID 38585839 Get It

Abstract Many cancers, including glioblastoma (GBM), have a male-biased sex difference in incidence and outcome. The underlying reasons for this sex bias are unclear but likely involve differences in tumor cell state and immune response. This effect is further amplified by sex hormones, including androgens, which have been shown to inhibit anti-tumor T cell immunity. Here, we show that androgens drive anti-tumor immunity in brain tumors, in contrast to its effect in other tumor types. Upon castration, tumor growth was accelerated with attenuated T cell function in GBM and brain tumor models, but the opposite was observed when tumors were located outside the brain. Activity of the hypothalamus-pituitary-adrenal gland (HPA) axis was increased in castrated mice, particularly in those with brain tumors. Blockade of glucocorticoid receptors reversed the accelerated tumor growth in castrated mice, indicating that the effect of castration was mediated by elevated glucocorticoid signaling. Furthermore, this mechanism was not GBM specific, but brain specific, as hyperactivation of the HPA axis was observed with intracranial implantation of non-GBM tumors in the brain. Together, our findings establish that brain tumors drive distinct endocrine-mediated mechanisms in the androgen-deprived setting and highlight the importance of organ-specific effects on anti-tumor immunity.
Influence of artificial intelligence on the diagnostic performance of endoscopists in the assessment of Barrett’s esophagus: a tandem randomized and video trial
Meinikheim, M. , Mendel, Robert , Scheppach, Markus W. , Nagl, Sandra , Schnoy, Elisabeth , Römmele, Christoph , Schulz, Dominik , Schlottmann, J., Prinz, Friederike, Rauber, David , Rückert, Tobias, Parsa, Nasim , Messmann, Helmut , Ebigbo, Alanna , Meinikheim, Michael , Römmele, Christoph , Matsumura, Tomoaki , Palm, Christoph , Probst, Andreas , Muzalyova, Anna , Fernández‐Esparrach, Glòria , Byrne, Michael F.

Endoscopy | March 29, 2024 | Volume: 56 | Issue: 09 | Pages: 641-649

10.1055/a-2296-5696 | PMID 38547927 Get It

Abstract Background This study evaluated the effect of an artificial intelligence (AI)-based clinical decision support system on the performance and diagnostic confidence of endoscopists in their assessment of Barrett’s esophagus (BE). Methods 96 standardized endoscopy videos were assessed by 22 endoscopists with varying degrees of BE experience from 12 centers. Assessment was randomized into two video sets: group A (review first without AI and second with AI) and group B (review first with AI and second without AI). Endoscopists were required to evaluate each video for the presence of Barrett’s esophagus-related neoplasia (BERN) and then decide on a spot for a targeted biopsy. After the second assessment, they were allowed to change their clinical decision and confidence level. Results AI had a stand-alone sensitivity, specificity, and accuracy of 92.2%, 68.9%, and 81.3%, respectively. Without AI, BE experts had an overall sensitivity, specificity, and accuracy of 83.3%, 58.1%, and 71.5%, respectively. With AI, BE nonexperts showed a significant improvement in sensitivity and specificity when videos were assessed a second time with AI (sensitivity 69.8% [95%CI 65.2%–74.2%] to 78.0% [95%CI 74.0%–82.0%]; specificity 67.3% [95%CI 62.5%–72.2%] to 72.7% [95%CI 68.2%–77.3%]). In addition, the diagnostic confidence of BE nonexperts improved significantly with AI. Conclusion BE nonexperts benefitted significantly from additional AI. BE experts and nonexperts remained significantly below the stand-alone performance of AI, suggesting that there may be other factors influencing endoscopists’ decisions to follow or discard AI advice.
Year in Review 2023: Noteworthy Literature in Cardiothoracic Transplantation
Saleem, Faiz , Liang, Hong , Martin, Archer Kilbourne , Martin, Archer Kilbourne

Seminars in Cardiothoracic and Vascular Anesthesia | March 28, 2024 | Volume: 28 | Issue: 2 | Pages: 106-112

10.1177/10892532241242973 | PMID 38548478 Get It

This review highlights key studies examining perioperative management of cardiothoracic transplantation published in 2023. Articles were manually screened after searching Scopus, PubMed, and Google Scholar databases for manuscripts related to cardiothoracic transplantation, which yielded 343 papers with 15 qualitatively selected as the most salient for readers. Overarching themes include differences in outcomes across the various etiologies of end-stage lung disease, novel developments to expand the donor pool, and multi-organ transplantation.
Two Decades of Insights into Nontuberculous Mycobacterial Hand Infections
Tabaja, Hussam , Saleem, Humza Y. , Bakri, Karim , Tabaja, Hussam , Tande, Aaron J.

Open Forum Infectious Diseases | March 28, 2024 | Volume: 11 | Issue: 4 | Pages: No page available

10.1093/ofid/ofae152 | PMID 38651140 Get It

Abstract Background The objective of our study is to describe the clinical presentation, management, and outcome of a large cohort with nontuberculous mycobacteria (NTM) hand infection. Methods We reviewed the medical records of all adults (≥18 years) managed at the Mayo Clinic (Rochester, MN) for NTM hand infection between 1998 and 2018. Results Our cohort included 81 patients. The median age was 61.3 (interquartile range 51.7, 69.6) years; 39.5% were immunocompromised, and 67.9% reported a triggering exposure preceding infection. Infection was deep in 64.2% and disseminated in 3.7%. Up to 16.0% received intralesional steroids because of misdiagnosis with an inflammatory process. Immunocompromised patients had deeper infection, and fewer reports of a triggering exposure. Mycobacterium marinum, Mycobacterium avium complex, and Mycobacterium chelonae/abscessus complex were the most common species. The median antibiotic duration was 6.1 (interquartile range 4.6, 9.9) months. Deep infection and infection with species other than M marinum were associated with using a greater number of antibiotics for combination therapy and an extended duration of treatment. Immunosuppression was also associated with longer courses of antibiotic therapy. Surgery was performed in 86.5% and 32.4% required multiple procedures. Ten patients, mostly with superficial infections, were treated with antibiotics alone. The 5-year cumulative rate of treatment failure was 30.3% (95% confidence interval, 20.9–44.0). Immunosuppression and intralesional steroid use were risk factors for failure. Conclusions Treatment of NTM hand infection usually requires surgery and antibiotics, but antibiotics alone may occasionally be attempted in select cases. Immunosuppression and intralesional steroids are risk factors for treatment failure.
Combined Wrist Extensor Tenodesis and Tendon Transfers for Severe Spastic Flexed Wrist Deformity: Surgical Technique and Case Series
Pino, Paula A. , Crowe, Christopher S. , Wu, Kitty Y. , Rhee, Peter C.

Techniques in Hand & Upper Extremity Surgery | March 28, 2024 | Volume: 28 | Issue: 3 | Pages: 154-159

10.1097/bth.0000000000000479 | PMID 38547039 Get It

Spastic wrist flexion deformities both limit the functional use of the hand for grasp and pinch producing a stigmatizing appearance. Tendon transfers and total wrist arthrodesis are treatment options for this condition depending on the patient’s characteristics, the latter the most commonly used in patients with severe wrist flexion deformities. Tendon transfers alone in this scenario have the tendency for recurrent deformity due to tenorrhaphy failure or soft tissue creep and resultant loss of tension. Total wrist arthrodesis is a more invasive procedure, which can have hardware or fusion problems and that is irreversible. We propose a novel technique that incorporates a distally based wrist extensor tendon slip and suture tape tenodesis to the distal radius. The rationale of this technique is to act as a protective, internal splint to prevent recurrent deformity after primary or revision tendon transfer for moderate to severe spastic flexed wrist deformities, avoiding the need to perform a total wrist arthrodesis.
Inter- and Intraobserver Variability on Endoscopic Scoring Systems in Crohn’s Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis
Ng, Faye Yu Ci , Colucci, Daniel , Baxi, Shrujal S. , Muneer, Sadaf, Reddan, Mitchell, Shingru, Pratik , Melmed, Gil , Melmed, Gil Y , Hashash, Jana G. , Farraye, Francis A. , Wang, Yeli

Inflammatory Bowel Diseases | March 28, 2024 | Volume: 30 | Issue: 11 | Pages: 2217-2226

10.1093/ibd/izae051 | PMID 38547325 Get It

Abstract Background Endoscopy scoring is a key component in the diagnosis of ulcerative colitis (UC) and Crohn’s disease (CD). Variability in endoscopic scoring can impact patient trial eligibility and treatment effect measurement. In this study, we examine inter- and intraobserver variability of inflammatory bowel disease endoscopic scoring systems in a systematic review and meta-analysis. Methods We included observational studies that evaluated the inter- and intraobserver variability using UC (endoscopic Mayo Score [eMS], Ulcerative Colitis Endoscopic Index of Severity [UCEIS]) or CD (Crohn’s Disease Endoscopic Index of Severity [CDEIS], Simple Endoscopic Score for Crohn’s Disease [SES-CD]) systems among adults (≥18 years of age) and were published in English. The strength of agreement was categorized as fair, moderate, good, and very good. Results A total of 6003 records were identified. After screening, 13 studies were included in our analysis. The overall interobserver agreement rates were 0.58 for eMS, 0.66 for UCEIS, 0.80 for CDEIS, and 0.78 for SES-CD. The overall heterogeneity (I2) for these systems ranged from 93.2% to 99.2%. A few studies assessed the intraobserver agreement rate. The overall effect sizes were 0.75 for eMS, 0.87 for UCEIS, 0.89 for CDEIS, and 0.91 for SES-CD. Conclusions The interobserver agreement rates for eMS, UCEIS, CDEIS, and SES-CD ranged from moderate to good. The intraobserver agreement rates for eMS, UCEIS, CDEIS, and SES-CD ranged from good to very good. Solutions to improve interobserver agreement could allow for more accurate patient assessment, leading to richer, more accurate clinical management and clinical trial data.
Brain Structural and Functional Abnormalities Associated with Acute Post-Traumatic Headache: Iron Deposition and Functional Connectivity
Nikolova, Simona , Li, Jing , Ross, Katherine , Starling, Amaal J. , Chong, Catherine, Starling, Amaal

No container title available | March 28, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-4165756/v1 | PMID 38585756 Get It

Abstract Background The purpose of this study was to interrogate brain iron accumulation in participants with acute post-traumatic headache (PTH) due to mild traumatic brain injury (mTBI), and to determine if functional connectivity is affected in areas with iron accumulation. We aimed to examine the correlations between iron accumulation and headache frequency, post-concussion symptom severity, number of mTBIs and time since most recent TBI. Methods Sixty participants with acute PTH and 60 age-matched healthy controls (HC) underwent 3T magnetic resonance imaging including quantitative T2* maps and resting-state functional connectivity imaging. Between group T2* differences were determined using T-tests (p < 0.005, cluster size threshold of 10 voxels). For regions with T2* differences, two analyses were conducted. First, the correlations with clinical variables including headache frequency, number of lifetime mTBIs, time since most recent mTBI, and Sport Concussion Assessment Tool (SCAT) symptom severity scale scores were investigated using linear regression. Second, the functional connectivity of these regions with the rest of the brain was examined (significance of p < 0.05 with family wise error correction for multiple comparisons). Results The acute PTH group consisted of 60 participants (22 male, 38 female) with average age of 42 ± 14 years. The HC group consisted of 60 age-matched controls (17 male, 43 female, average age of 42 ± 13). PTH participants had lower T2* values compared to HC in the left posterior cingulate and the bilateral cuneus. Stronger functional connectivity was observed between bilateral cuneus and right cerebellar areas in PTH compared to HC. Within the PTH group, linear regression showed negative associations of T2* and SCAT symptom severity score in the left posterior cingulate (p = 0.05) and with headache frequency in the left cuneus (p = 0.04). Conclusions Iron accumulation in posterior cingulate and cuneus was observed in those with acute PTH relative to HC; stronger functional connectivity was detected between the bilateral cuneus and the right cerebellum. The correlations of decreased T2* (suggesting higher iron content) with headache frequency and post mTBI symptom severity suggest that the iron accumulation that results from mTBI might reflect the severity of underlying mTBI pathophysiology and associate with post-mTBI symptom severity including PTH.
Plain language summary of the TRANSFORM study primary analysis results: liso-cell as a second treatment regimen for large B-cell lymphoma following failure of the first treatment regimen
Abramson, Jeremy S, Solomon, Scott R. , Arnason, Jon , Johnston, Patrick B., Glaß, Bertram , Bachanová, Veronika , Mielke, Stephan , Mutsaers, Pim , Hernandez‐Ilizaliturri, Francisco J. , Lunning, Matthew A. , Crotta, Alessandro, Montheard, Sandrine, Previtali, Alessandro , Kamdar, Manali , Bachanova, Veronika , Kamdar, Manali , Mielke, Stephan , Abramson, Jeremy S, Johnston, Patrick B. , Ibrahimi, Sami , Izutsu, Koji , Morschhauser, Franck , Ogasawara, Ken

Future Oncology | March 28, 2024 | Volume: 20 | Issue: 21 | Pages: 1455-1465

10.2217/fon-2023-0898 | PMID 38547003 Get It

Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials
Gallois, Claire , Shi, Qian , Pederson, Levi , André, Thierry , Sobrero, Alberto F. , Alberts, Steven R. , Gramont, Aimery de , Meyerhardt, Jeffrey A. , George, Thomas J. , Souglakos, Ioannis , Harkin, Andrea , Shields, Anthony F. , Boukovinas, Ioannis , Goldberg, Richard M. , Papamichael, Demetris , Pederson, Levi D , Iveson, Timothy J , Sobrero, Alberto , Alberts, Steven R , De Gramont, Aimery , Meyerhardt, Jeffrey A , George, Thomas J , Schmoll, Hans-Joachim , Harkin, Andrea , Sinicrope, Frank A , Oki, Eiji , Shields, Anthony F , Boukovinas, Ioannis , Lonardi, Sara , Yothers, Greg , Yoshino, Takayuki , Goldberg, Richard M , Taieb, Julien , Papamichael, Demetris , André, Thierry , Shi, Qian , Iveson, Timothy , Schmoll, Hans‐Joachim , Labianca, Roberto , Sinicrope, Frank A. , Oki, Eiji , Kerr, Rachel , Lonardi, Sara , Yothers, Greg , Yoshino, Takayuki , Taı̈eb, Julien

Journal of Clinical Oncology | March 28, 2024 | Volume: 42 | Issue: 19 | Pages: 2295-2305

10.1200/jco.23.01326 | PMID 38547438 Get It

PURPOSE A number of studies suggest that older patients may have reduced or no benefit from the addition of oxaliplatin to fluoropyrimidines as adjuvant chemotherapy for stage III colon cancer (CC). MATERIALS AND METHODS We studied the prognostic impact of age, as well as treatment adherence/toxicity patterns according to age, in patients with stage III CC who received 3 or 6 months of infusional fluorouracil, leucovorin, and oxaliplatin/capecitabine and oxaliplatin (CAPOX) on the basis of data collected from trials from the ACCENT and IDEA databases. Associations between age and time to recurrence (TTR), disease-free survival (DFS), overall survival (OS), survival after recurrence (SAR), and cancer-specific survival (CSS) were assessed by a Cox model or a competing risk model, stratified by studies and adjusted for sex, performance status, T and N stage, and year of enrollment. RESULTS A total of 17,909 patients were included; 24% of patients were age older than 70 years (n = 4,340). Patients age ≥70 years had higher rates of early treatment discontinuation. Rates of grade ≥3 adverse events were similar between those older and younger than 70 years, except for diarrhea and neutropenia that were more frequent in older patients treated with CAPOX (14.2% v 11.2%; P = .01 and 12.1% v 9.6%; P = .04, respectively). In multivariable analysis, TTR was not significantly different between patients <70 years and those ≥70 years, but DFS, OS, SAR, and CSS were significantly shorter in those patients ≥70 years. CONCLUSION In patients ≥70 years with stage III CC fit enough to be enrolled in clinical trials, oxaliplatin-based adjuvant chemotherapy was well tolerated and led to similar TTR compared with younger patients, suggesting similar efficacy. TTR may be a more appropriate end point for efficacy in this patient population.